DNA Repair Drugs: Global Markets

DNA Repair Drugs: Global Markets

Report Code: BIO221A

Publish Date: Mar 2022

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global DNA repair drugs market should reach $19.5 billion by 2026 from $7.5 billion in 2021 at a compound annual growth rate (CAGR) of 21.0% for the forecast period of 2021 to 2026.

Report Includes

  • 20 data tables and 20 additional tables
  • A brief general outlook of the global markets for DNA repair drugs within the biotech industry
  • Analyses of the global market trends, with data from 2020 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Discussion of major factors driving the growth of global DNA repair drugs market, industry structure, regulatory scenario and penetration of technologies within the marketplace
  • Highlights of key market dynamics (DROs), current trends and emerging applications, federal regulations and opportunity assessment of next generation technologies anticipated to drive the progress of this market
  • Evaluation of current market size and revenue forecast for DNA repair drugs in dollar value terms, and corresponding market share analysis by technology type, application and region
  • Assessment of new developments relate to DNA research and type classification, their improvement techniques, focused scene investigation and patterns of advancements
  • Insight into the R&D spendings in the pharmaceutical industry, approval of new drugs, projected revenues and cost analyses
  • Emphasis on the SARS-CoV-2 Infection Impairs on DNA repair and inhibits
  • Profile descriptions of the leading market players, including AbbVie, Bayer AG, Eli Lilly and Co., Johnson & Johnson, Novartis and Sanofi

Report Scope

This report provides an in-depth examination of the healthcare industry, with a particular emphasis on global market trend analysis. The report's goal is to provide an overview of the market for DNA repair drugs, as well as market segmentation by type, application and geography. During the forecast period, the market for DNA repair drugs is expected to grow rapidly. The report provides key statistics on the market status of the leading players in the DNA repair drug market, as well as key market trends and opportunities.

Report Synopsis

Report Metrics Details
Base year considered 2020
Forecast period considered 2021-2026
Base year market size $6.2 billion
Market size forecast $19.5 billion
Growth rate CAGR of 21% from 2021 to 2026
Units considered $ Billions
Segments covered Type, Application
Regions covered North America, Europe, Asia, Rest of the World (RoW)
Countries covered U.S., Mexico, Canada, France, Germany, Italy, China, India
Key Market Drivers
  • Rising Prevalence of Cancer Worldwide
  • Favorable Reimbursement Scenarios
  • Increasing Oncology R&D Expenditures
  • An Increase in the Adoption of Precision Medicine in Cancer Treatment
Companies studied
ABBVIE INC.AMGEN INC.
ABBOTTASTRAZENECA
BAYER AGBRISTOL-MYERS SQUIBB CO.
ELI LILLY AND CO.F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.GSK PLC.
JOHNSON & JOHNSON SERVICES INC.MERCK & CO. INC.
MERCK KGAANOVARTIS AG
PFIZER INC.SANOFI
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: DNA Repair Drugs: Global Markets112Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background22Free
Chapter- 4: Market Breakdown by Technology Type9Free
Chapter- 5: Market Breakdown by Application10Free
Chapter- 6: Market Breakdown by Region9Free
Chapter- 7: R&D in the Pharmaceutical Industry10Free
Chapter- 8: DNA Repair Inhibitors on SARS-CoV-25Free
Chapter- 9: Company Profiles38Free

Related Reports

Human Recombinant DNA: Global Markets

Published - Aug 2022 | Publisher - BCC Publishing | Code - BIO232A

The global human recombinant DNA market should reach $348.7 billion by 2022 and more than $496.9 billion by 2027, with a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2022-2027.

Breast Cancer Diagnostic and Drug Technologies: Global Markets

Published - Dec 2019 | Publisher - BCC Publishing | Code - HLC106D

The global breast cancer diagnostic and drug market should reach $28.2 billion by 2024 from $20.9 billion in 2019 at a compound annual growth rate (CAGR) of 6.2% for the forecast period of 2019 to 2024.

Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022

Published - May 2018 | Publisher - BCC Publishing | Code - HLC143B

The global ovarian cancer therapeutic market reached $2.1 billion in 2017. The market should reach $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.1% during 2017-2022.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 40

  • Summary Table: Global Market for DNA Repair Drugs, by Type, Through 2026
  • Table 1: Global Market for DNA Repair Drugs, by Type, Through 2026
  • Table 2: FDA-Approved PARP Inhibitors
  • Table 3: Global Market for DNA Repair Drugs, by Application, Through 2026
  • Table 4: Global Market for DNA Repair Drugs, by Region, Through 2026
  • Table 5: North American Market for DNA Repair Drugs, by Country, Through 2026
  • Table 6: European Market for DNA Repair Drugs, by Country, Through 2026
  • Table 7: Asia-Pacific Market for DNA Repair Drugs, by Country, Through 2026
  • Table 8: Rest of the World Market for DNA Repair Drugs, Through 2026
  • Table 9: AbbVie: Oncology Pharmaceutical Revenue, 2018-2020
  • Table 10: AbbVie: Oncology Pharmaceutical Products Portfolio
Sample Report

Recent Reports

Global Biotechnology Equipment Market

Published - Aug 2025 | Publisher - BCC Publishing | Code - BIO273A

The global market for biotechnology equipment was valued at $87.8 billion in 2024 and is estimated to increase from $95.1 billion in 2025 to reach $143.9 billion by 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 through 2030.

Chromatography in Pharmaceuticals and Biotechnology: Global Markets

Published - Aug 2025 | Publisher - BCC Publishing | Code - BIO163B

The global market for chromatography in pharmaceuticals and biotechnology is estimated to grow from $13.3 billion in 2025 to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.

Genome Editing: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO146D

The global market for genome editing is expected to grow from $10.8 billion in 2025 and is projected to reach $23.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.9% during the forecast period of 2025 to 2030.

Global Assisted Reproductive Technologies Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO270A

The report provides an analysis of the global assisted reproductive technologies market and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented into procedure, product, end user, and region. The report focuses on the significant trends, challenges and technological advancements that alter the market and vendor landscape.

Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO269A

The global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics is expected to grow from $33.3 billion in 2025 and is projected to reach $52.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
DNA Repair Drugs: Global Markets
Customize Report
AI: Your Say